Most of our engagement opportunities will be in therapeutic areas of interest to Roche which include the following: cancer (breast, lung, kidney, bladder, and blood cancers), hemophilia, idiopathic pulmonary fibrosis, multiple sclerosis, rheumatoid arthritis, spinal muscular atrophy (SMA), ophthalmology, Angelman syndrome, and Alzheimer’s disease.